Market Place
Axplora- The partner of choice for complex APIs. 
X
Please Wait
Applying Filters...
01 Farmabios S.p.A. (1)
02 NURAY CHEMICALS PRIVATE LIMITED (1)
03 Curia Spain S.A.U. (1)
04 Apicore US LLC (1)
05 LETCO MEDICAL, LLC (1)
06 Medisca Inc. (1)
07 Professional Compounding Centers of America dba PCCA (1)
08 Sicor S.r.l. (1)
01 FLUDROCORTISONE ACETATE (3)
02 Fludrocortisone Acetate (3)
03 Fludrocortisone Acetate Micron. (1)
04 Fludrocortisone acetate (1)
01 Germany (1)
02 India (2)
03 Italy (1)
04 U.S.A (3)
05 United Kingdom (1)
RDD 2024
Not Confirmed
Contact Supplier
RDD 2024
Not Confirmed
Contact Supplier
81
PharmaCompass offers a list of Fludrocortisone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fludrocortisone Acetate manufacturer or Fludrocortisone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fludrocortisone Acetate manufacturer or Fludrocortisone Acetate supplier.
PharmaCompass also assists you with knowing the Fludrocortisone Acetate API Price utilized in the formulation of products. Fludrocortisone Acetate API Price is not always fixed or binding as the Fludrocortisone Acetate Price is obtained through a variety of data sources. The Fludrocortisone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate, including repackagers and relabelers. The FDA regulates (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate supplier is an individual or a company that provides (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate active pharmaceutical ingredient (API) or (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate finished formulations upon request. The (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate suppliers may include (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate API manufacturers, exporters, distributors and traders.
click here to find a list of (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate suppliers with NDC on PharmaCompass.
We have 8 companies offering (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate
Get in contact with the supplier of your choice:
